SRC Sigmaroc Plc

 
TIDMASM 
 
London, UK, and Cambridge, MA: 20 July 2010 - Antisoma plc (LSE: ASM; USOTC: 
ATSMY) will be announcing its Preliminary Results for the year ended 30 June 
2010 on Thursday 29 July 2010. 
 
 
Enquiries: 
 
Daniel Elger 
VP, Marketing & Communications 
Antisoma plc 
+44 7909 915 068 
 
Mark Court/Lisa Baderoon/Catherine Breen 
Buchanan Communications 
+44 (0)20 7466 5000 
 
Background on Antisoma 
Antisoma is a London Stock Exchange-listed biopharmaceutical company that 
develops novel products for the treatment of cancer. The Company has operations 
in the UK and the US. Please visitwww.antisoma.com for further information about 
Antisoma. 
 
 
[HUG#1432737] 
 
 
 
 
 
 
 
 
This announcement is distributed by Thomson Reuters on behalf of 
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
 
Source: Antisoma plc via Thomson Reuters ONE 
 

Sigmaroc (LSE:SRC)
Historical Stock Chart
From Apr 2024 to May 2024

Sigmaroc (LSE:SRC)
Historical Stock Chart
From May 2023 to May 2024